2026 ICD-10-CM Diagnosis Code Q99.813Usher syndrome, type 3
Q99.813 is a billable ICD-10-CM diagnosis code for usher syndrome, type 3. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 564 through 566. The code is exempt from POA reporting.
Code Identity
Code Classification
Present on Admission (POA)Billing
Q99.813 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Index to Diseases and InjuriesGuidance
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Syndrome
- usher
- type 3
Clinical InformationClinical
Usher Syndrome Type 3
a syndrome characterized by postlingual progressive hearing loss, abnormalities in the vestibular system, and onset of retinitis pigmentosa symptoms usually by the second decade of life.
Code History & ChangesHistory
New Code Q99.813 was added to the ICD-10-CM code set for FY 2026, effective October 1, 2025.
Replacement Q99.813 replaces the following previously assigned code(s):
- Q99.8 - Other specified chromosome abnormalities
Questions About Q99.813Overview
Is Q99.813 (Usher syndrome) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report usher syndrome, type 3 on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does Q99.813 group to?
When usher syndrome, type 3 is the principal diagnosis on an inpatient stay, it groups to MS-DRG 564, 565, 566, with relative weights from 0.7493 to 1.5436 depending on complications. Higher weights mean higher Medicare reimbursement.
Is Q99.813 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for usher syndrome, type 3 on inpatient claims.
